SWEDISH ORPHAN BIOVITRUM
Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies
- Conditions
- Hemophilia A
- Interventions
- Biological: Recombinant coagulation factor (rFVIIIFc)
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 16
- Registration Number
- NCT03103542
- Locations
- 🇬🇧
Swedish Orphan Biovitrum Research Site, London, United Kingdom
🇸🇪Swedish Orphan Biovitrum Research site, Gothenburg, Sweden
A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 201
- Registration Number
- NCT03055611
- Locations
- 🇩🇪
Swedish Orphan Biovitrum Reserach site, Münster, Germany
🇩🇪Swedish Orphan Biovitrum Reserach Site, Mörfelden-Walldorf, Germany
🇩🇪Swedish Orphan Biovitrum Research Site, Würzburg, Germany
A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis
- Conditions
- Acute Gouty Arthritis
- Interventions
- Drug: Placebo to Anakinra 100 mg
- First Posted Date
- 2016-12-26
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 165
- Registration Number
- NCT03002974
- Locations
- 🇺🇸
Clinical Trials Management, Metairie, Louisiana, United States
🇺🇸Clinical Research Solutions - Franklin, Franklin, Tennessee, United States
🇺🇸Advanced Research Center, Anaheim, California, United States
Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 361
- Registration Number
- NCT02976753
- Locations
- 🇮🇹
Swedish Orphan Biovitrum Research Site, Padova, Italy
🇬🇧Swedish Orphan Biovitrum Reserach site, London, United Kingdom
🇪🇸Swedish Orphan Biovitrum research site, Alicante, Spain
Kineret in the Treatment of Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2016-09-26
- Last Posted Date
- 2017-08-11
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 30
- Registration Number
- NCT02915094
- Locations
- 🇩🇪
Swedish Orphan Biovitrum Investigational Site, Freiburg, Germany
Kineret CAPS Post Authorisation Study
- First Posted Date
- 2014-12-29
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 12
- Registration Number
- NCT02326376
- Locations
- 🇬🇧
Swedish Orphan Biovitrum Investigational Site, London, United Kingdom
Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2015-11-11
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 18
- Registration Number
- NCT02323529
- Locations
- 🇸🇪
Swedish Orphan Biovitrum Investigational site, Gothenburg, Sweden
🇩🇪Swedish Orphan Biovitrum Investigational Site, Reutlingen, Germany
Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care
- First Posted Date
- 2014-12-19
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 315
- Registration Number
- NCT02320084
- Locations
- 🇬🇧
Swedish Orphan Biovitrum Investigational Site, Sheffield, United Kingdom
🇬🇧Swedish Oprhan Biovitrum Investigational Site, Manchester, United Kingdom
Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration
- First Posted Date
- 2014-03-11
- Last Posted Date
- 2015-07-28
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 24
- Registration Number
- NCT02083666
- Locations
- 🇬🇧
Richmond Pharmacology Ltd., London, St George's University of London, United Kingdom
A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody
- First Posted Date
- 2014-02-24
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 58
- Registration Number
- NCT02069899
- Locations
- 🇬🇧
Great Ormond Street Hospital - Department of Haematology, London, United Kingdom
🇮🇹Azienda Ospedaliera Padova, Padova, Italy
🇮🇹Ospedale della Donna e del Bambino - U.O.C. Oncoematologia Pediatrica, Verona, Italy